1044 / 1241
Response Criteria in Solid Tumours: RECIST 1.1
Target lesions:
Longest dimension except
nodes (short axis)
Eisenhauer et al. Eur J Cancer 2009;45:228-47
Therasse P et al. J Natl Cancer Inst 2000
Response classification:
Complete remission (CR)
Partial remission (PR)
Stable disease (SD)
Progressive disease (PD)
Validated response biomarker:
Clinical trial end point
that has proven useful for
screening new therapeutic
agents
Phase II/III trials